Calculator topics: Difference between revisions

Jump to navigation Jump to search
Ssharfaei (talk | contribs)
Ssharfaei (talk | contribs)
 
(11 intermediate revisions by 2 users not shown)
Line 16: Line 16:
|-
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |ACTION ICU Score for Intensive Care in NSTEMI
| align="left" style="background:#F5F5F5;" + |[[ACTION ICU risk score]]
| align="left" style="background:#F5F5F5;" + |Predicts risk of NSTEMI complications requiring ICU care
| align="left" style="background:#F5F5F5;" + |Predicts need for ICU care in stable adults with [[Unstable angina / non ST elevation myocardial infarction|NSTEMI]]
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
Line 31: Line 31:
|-
|-
! align="center" style="background:#DCDCDC;" + |Anticoagulation
! align="center" style="background:#DCDCDC;" + |Anticoagulation
| align="left" style="background:#F5F5F5;" + |ATRIA Bleeding Risk Score
| align="left" style="background:#F5F5F5;" + |ATRIA bleeding risk score
| align="left" style="background:#F5F5F5;" + |Determines bleeding risk for patients on warfarin
| align="left" style="background:#F5F5F5;" + |Determines bleeding risk for patients on warfarin
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |Arrythmia
! align="center" style="background:#DCDCDC;" + |Arrythmia
| align="left" style="background:#F5F5F5;" + |ATRIA Stroke Risk Score
| align="left" style="background:#F5F5F5;" + |ATRIA stroke risk score
| align="left" style="background:#F5F5F5;" + |Determines stroke risk in patients with atrial fibrillation
| align="left" style="background:#F5F5F5;" + |Determines stroke risk in patients with atrial fibrillation
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke
| align="left" style="background:#F5F5F5;" + |Atrial Fibrillation Five Year Risk of Stroke (Framingham Heart Study)
| align="left" style="background:#F5F5F5;" + |Atrial fibrillation 5-year risk of stroke (Framingham Heart Study)
| align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke in patients with atrial fibrillation
| align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke in patients with atrial fibrillation
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke
| align="left" style="background:#F5F5F5;" + |Atrial Fibrillation Five Year Risk of Stroke or Death (Framingham Heart Study)
| align="left" style="background:#F5F5F5;" + |Atrial fibrillation 5-year risk of stroke or death (Framingham Heart Study)
| align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke or death in patients with atrial fibrillation
| align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke or death in patients with atrial fibrillation
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |Alcoholism
! align="center" style="background:#DCDCDC;" + |Alcoholism
| align="left" style="background:#F5F5F5;" + |CAGE Questions for Alcohol Use
| align="left" style="background:#F5F5F5;" + |CAGE questions
| align="left" style="background:#F5F5F5;" + |Screens for excessive drinking and alcoholism
| align="left" style="background:#F5F5F5;" + |Screens for excessive drinking and alcoholism
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |Syncope
! align="center" style="background:#DCDCDC;" + |Syncope
| align="left" style="background:#F5F5F5;" + |Canadian Syncope Risk Score
| align="left" style="background:#F5F5F5;" + |Canadian syncope risk score
| align="left" style="background:#F5F5F5;" + |Predicts 30-day serious adverse events in patients presenting with syncope
| align="left" style="background:#F5F5F5;" + |Predicts 30-day serious adverse events in patients presenting with syncope
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
Line 116: Line 116:
|-
|-
! align="center" style="background:#DCDCDC;" + |VTE
! align="center" style="background:#DCDCDC;" + |VTE
| align="left" style="background:#F5F5F5;" + |DASH Prediction Score for Recurrent VTE
| align="left" style="background:#F5F5F5;" + |[[DASH prediction score]]
| align="left" style="background:#F5F5F5;" + |Predicts likelihood of recurrence of first VTE
| align="left" style="background:#F5F5F5;" + |Predicts disease recurrence in patients with prior unprovoked [[Venous thromboembolism|VTE]]
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |DAPT (Dual Antiplatelet Therapy) Score
| align="left" style="background:#F5F5F5;" + |[[DAPT score]]
| align="left" style="background:#F5F5F5;" + |Predicts which patients will benefit from prolonged DAPT after coronary stent placement
| align="left" style="background:#F5F5F5;" + |Predicts which patients will benefit from prolonged [[dual antiplatelet therapy]] after coronary stent placement
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
Line 196: Line 196:
|-
|-
! align="center" style="background:#DCDCDC;" + |Bleeding
! align="center" style="background:#DCDCDC;" + |Bleeding
| align="left" style="background:#F5F5F5;" + |IMPROVE bleeding risk score
| align="left" style="background:#F5F5F5;" + |[[IMPROVE bleeding risk score]]
| align="left" style="background:#F5F5F5;" + |Estimates the probability of major or clinically important in-hospital bleeding from the time of hospital admission up to 14 days following admission
| align="left" style="background:#F5F5F5;" + |Estimates the probability of major or clinically important in-hospital bleeding from the time of hospital admission up to 14 days following admission
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |VTE
! align="center" style="background:#DCDCDC;" + |VTE
| align="left" style="background:#F5F5F5;" + |[[IMPROVE risk score calculator|IMPROVE VTE risk score]]
| align="left" style="background:#F5F5F5;" + |[[IMPROVE VTE risk score]]
| align="left" style="background:#F5F5F5;" + |Estimates the probability of clinically evident acute venous thromboembolism from the time of hospital admission to discharge
| align="left" style="background:#F5F5F5;" + |Estimates the probability of clinically evident acute venous thromboembolism from the time of hospital admission to discharge
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
Line 271: Line 271:
|-
|-
! align="center" style="background:#DCDCDC;" + |DVT
! align="center" style="background:#DCDCDC;" + |DVT
| align="left" style="background:#F5F5F5;" + |[[Modified Wells score calculator for DVT|Wells score for DVT, modified]]
| align="left" style="background:#F5F5F5;" + |[[Wells score for DVT (original)]]
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of DVT
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of DVT
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |DVT
! align="center" style="background:#DCDCDC;" + |DVT
| align="left" style="background:#F5F5F5;" + |[[Wells score calculator for DVT|Wells score for DVT, original]]
| align="left" style="background:#F5F5F5;" + |[[Wells score for DVT (modified)]]
| align="left" style="background:#F5F5F5;" + |Calculates Wells' Score for risk of DVT
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of DVT
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |PE
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |[[Pulmonary embolism Wells score calculator|Wells score for Pulmonary Embolism]]
| align="left" style="background:#F5F5F5;" + |[[Wells score for PE (original)]]
| align="left" style="background:#F5F5F5;" + |Objectifies risk of pulmonary embolism
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of PE
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
|-
|-
! align="center" style="background:#DCDCDC;" + |PE
! align="center" style="background:#DCDCDC;" + |PE
| align="left" style="background:#F5F5F5;" + |[[Pulmonary embolism modified Wells score calculator|Wells score for pulmonary embolism, modified]]
| align="left" style="background:#F5F5F5;" + |[[Wells score for PE (modified)]]
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of PE
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of PE
| align="center" style="background:#F5F5F5;" + |Score
| align="center" style="background:#F5F5F5;" + |Score
Line 441: Line 441:
|-
|-
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
! align="center" style="background:#DCDCDC;" + |Coronary artery disease
| align="left" style="background:#F5F5F5;" + |Sgarbossa's Criteria for MI in Left Bundle Branch Block
| align="left" style="background:#F5F5F5;" + |[[Sgarbossa's criteria]]
| align="left" style="background:#F5F5F5;" + |Criteria to diagnose acute MI in patients with prior LBBB
| align="left" style="background:#F5F5F5;" + |Assists to diagnose acute [[ST elevation myocardial infarction|MI]] in patients with [[Left bundle branch block|LBBB]]
| align="center" style="background:#F5F5F5;" + |Criteria
| align="center" style="background:#F5F5F5;" + |Criteria
|-
|-

Latest revision as of 06:02, 10 February 2019

Calculator project
Introduction
Guide
Template
Topics
Validated Scores
Alphabetic Order

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

CARDIOLOGY

CRITICAL CARE

GASTROENTEROLOGY

HEMATOLOGY/ONCOLOGY

INFECTIOUS DISEASE

NEPHROLOGY

NEUROLOGY

PEDIATRICS

PULMONOLOGY

ORTHOPEDICS

SURGERY